In the fiercely competitive world of pharmaceuticals, securing market exclusivity isn’t just about innovation — it’s about strategic legal maneuvers that can make or break a company’s bottom line. Yet, what if the very patents that grant exclusivity ar…
Attack First: How to Challenge Drug Patents and Capture Market Exclusivity Read Post »
In the high-stakes world of pharmaceuticals, the race to secure market share isn’t just about developing groundbreaking drugs—it’s about mastering the complex chessboard of global patent strategies. As the industry faces mounting pressure from regulato…
In the high-stakes world of pharmaceuticals, timing is everything. When a blockbuster drug faces patent challenges or impending patent expirations, the market’s response can be swift and seismic. Yet, for many players—be it generic manufacturers, inves…
In the high-stakes world of pharmaceuticals, the question isn’t just about the efficacy of a drug — it’s about the intricate web of money that fuels its journey from lab to patient. A recent investigation by Drug Patent Watch exposes a startling realit…
The Price of Access: How Drug Money Flows Into the FDA — and What It Actually Buys Read Post »
In the fiercely competitive world of pharmaceuticals, staying ahead isn’t just about innovation — it’s about strategic intelligence. As patent cliffs loom and generic competitors threaten market share, how can IP teams, R&D leaders, and institution…
ð¨ The Hidden Gap in Pharma Transparency: Why Orange Book Dates Don’t Match When Generics Enter the Market—and What You Need to Know
In the complex world of pharmaceutical regulation and market dynamics, timing is everything. Yet, a critical disconne…
In the high-stakes world of pharmaceuticals, understanding the true lifespan of a drug’s market exclusivity isn’t just a matter of academic interest—it’s a critical factor that can make or break billions in investment decisions. Yet, many industry play…
Unlocking Revenue Growth in Pharma Supply: The Ultimate Playbook for Sales Success
In the fiercely competitive world of pharmaceutical supply, standing out isn’t just about offering quality products—it’s about understanding the intricate revenue trigge…
The LOE Sales Playbook: 100 Revenue Triggers for Pharmaceutical Supply Vendors Read Post »
Are Pharma Vendors Losing Millions Because They’re Tracking Patent Expiry Wrong?
In the high-stakes world of pharmaceutical innovation, timing isn’t just everything—it’s the difference between securing market dominance and watching billions slip away. …
“We Missed the LOE Date”: How Pharma Vendors Lose Millions by Tracking Expiry Wrong Read Post »
The Patent Cliff Illusion: Why Generics Don’t Always Launch as Expected — And What It Means for the Future of Pharma
In the high-stakes world of pharmaceuticals, the concept of the “patent cliff” has long been a looming specter for drugmakers. When blo…
The Patent Cliff Illusion: Why Generics Don’t Always Launch Read Post »
Get new actionable insights and updates from BiotechBlog
